E
CNXC icon

Ergoteles’s Concentrix CNXC Stock Holding History

Ergoteles’s Portfolio CNXC Stock Details CNXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-43,280
Closed -$4.83M – 1518
2022
Q3 		$4.83M Buy
43,280
+15,246
+54% +$1.95M 0.17% 120
2022
Q2 		$3.8M Buy
+28,034
New +$4.22M 0.11% 189
2021
Q4 		– Sell
-1,887
Closed -$334K – 1292
2021
Q3 		$334K Sell
1,887
-24,629
-93% -$4.08M 0.01% 751
2021
Q2 		$4.26M Buy
26,516
+6,488
+32% +$998K 0.1% 248
2021
Q1 		$3M Buy
20,028
+8,409
+72% +$1.02M 0.09% 229
2020
Q4 		$1.15M Buy
+11,619
New +$1.16M 0.04% 311

Other funds holding CNXC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ergoteles's CNXC Position: Q4 2022 in Review

Ergoteles sold out of Concentrix (CNXC) in Q4 2022, closing a stake of 43,280 shares — an estimated $4.83M sold.

Ergoteles first reported a position in CNXC in Q4 2020 and held it in 6 quarters. The position peaked at $4.83M in Q3 2022. 321 funds tracked by Wall St. Rank hold CNXC as of Q4 2022.

  • Ergoteles reported no remaining Concentrix position as of Q4 2022 after selling out during the quarter.
  • Ergoteles sold 43,280 Concentrix shares in Q4 2022, an estimated $4.83M.
  • Ergoteles first reported a position in Concentrix in Q4 2020 and held it in 6 quarters.
  • Ergoteles's Concentrix position peaked at $4.83M in Q3 2022.
  • 321 funds tracked by Wall St. Rank held Concentrix as of Q4 2022.

Based on Ergoteles's 13F filing for Q4 2022, filed 14 Feb 2023.